How Novo Nordisk's Weight-Loss Drug Could Unlock A Better Future For Biogen's Alzheimer's Treatment

benzinga.com/news/health-care/25/08/47101211/how-novo-nordisks-weight-loss-drug-could-unlock-a-better-future-for-biogens-alzheimers-treatment

Biogen Inc. (NASDAQ:BIIB) CEO Chris Viehbacher said a successful Alzheimer’s trial for Novo Nordisk A/S’ (NYSE:NVO) weight-loss drug wouldn’t threaten his company’s treatment but could instead open the door to combining therapies for stronger results.
In an interview with Bloomberg News,…

This story appeared on benzinga.com, 2025-08-13 17:49:22.
The Entire Business World on a Single Page. Free to Use →